CBLL1 and malignant colon neoplasm: Furthermore, Hakai expression progressively increases in adenoma (non-malignant tissue) and in different TNM stages (I–IV) of colon cancer patients compared to adjacent colon healthy tissues, highlighting the potential of Hakai as a biomarker for CRC progression [22].